|
|
|
|
|
|
|
|
Abstract
Article first published online: 30 SEP 2015
The
Japan Society of Obstetrics and Gynecology collects and analyzes annual
data on gynecologic cancers from member institutions. Here we present
the Treatment Annual Report for 2007. Data on the prognosis of 3381
patients with cervical cancer, 3681 with endometrial cancer, and 2367
with ovarian cancer for whom treatment was initiated in 2007 were
analyzed in the Treatment Annual Report. In the 2007 Treatment Annual
Report, stage I accounted for 53.1%, stage II for 24.4%, stage III for
14.2%, and stage IV for 8.3% of all patients with cervical cancer. Stage
I accounted for 64.8%, stage II for 8.2%, stage III for 20.2%, and
stage IV for 6.9% of all patients with endometrial cancer. Stage I
accounted for 41.4%, stage II for 9.9%, stage III for 30.6%, and stage
IV for 8.6% of all patients with ovarian cancer.
The
5-year overall survival rates for patients with cervical cancer were
91.8% for stage I, 71.5% for stage II, 53.0% for stage III, and 23.7%
for stage IV; those for patients with endometrial cancer were 95.3%,
89.8%, 75.6%, and 29.1%, and those for patients with ovarian surface
epithelial–stromal tumors were 91.5%, 76.1%, 46.9%, and 31.3%,
respectively.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.